Diabetes Research
To learn more about diabetes and ongoing clinical trials in this area, visit our Diabetes Research page.
The main purpose of this study is to assess the safety and efficacy of orforglipron compared with dapagliflozin in improving blood sugar control in participants with type 2 diabetes (T2D) with inadequate glycemic control using metformin.
Have Type 2 diabetes
Have been on stable diabetes treatment with metformin 90 days before study start through randomization
Have not lost or gained body weight for at least 90 days prior to baseline and agree to not start an intensive diet or exercise program during the study with the intent to lose body weight other than lifestyle and/or dietary measures for diabetes treatment
Have Type 1 Diabetes
Have a history of severe hypoglycemia or hypoglycemia unawareness within the last 6 months prior to baseline
Have had congestive heart failure
Have had heart attack, stroke or hospitalized for congestive heart failure
To learn more about diabetes and ongoing clinical trials in this area, visit our Diabetes Research page.
A clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.